News Quantified

ZYME – zymeworks inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Zymeworks Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]

Zymeworks Q4 Earnings Call Highlights [Yahoo! Finance]

Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing [Yahoo! Finance]

Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing

Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results

0.1%

MISS

-8.0%

BEAT

-1.2%

BEAT

-0.1%

BEAT

Wells Fargo & Company

Wells Fargo & Company

Form S-8 Zymeworks Inc.

Form 8-K Zymeworks Inc. For: Mar 02

Form 10-K Zymeworks Inc. For: Dec 31

Form 8-K Zymeworks Inc. For: Mar 02

Form 144 Zymeworks Inc. Filed by: PATTERSON LEONE D

Top News Gainers

3/16 Form 3 Zymeworks Inc. For: Mar 16 Filed by: 667, L.P. 14.0%

3/23 Form DEF 14A Zymeworks Inc. For: May 07 12.5%

1/28 Form 4 Zymeworks Inc. For: Jan 27 Filed by: Cox Troy 12.5%

3/30 Zymeworks Inc (NYSE: ZYME) was downgraded by analysts at TheStreet from a "c" rating to a "d+" rating. 11.1%

11/22 Zymeworks Highlights Advancing Clinical Collaboration with BeiGene and Updated ZW25 Phase 1 Data in HER2-Expressing Cancers at ESMO Asia Congress 9.7%

6/19 Zymeworks Announces Pricing of $175.0 Million Public Offering 9.6%

1/13 Form 8-K Zymeworks Inc. For: Jan 12 8.8%

2/8 Zymeworks Inc (NYSE: ZYME) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $51.00 price target on the stock. 7.1%

6/20 Form 424B5 Zymeworks Inc. 7.1%

1/21 Form 424B5 Zymeworks Inc. 6.0%

Top News Decliners

3/16 Zymeworks Appoints Dr. Kelvin Neu to the Board of Directors -16.2%

3/11 Form 4 Zymeworks Inc. For: Mar 10 Filed by: Tehrani Ali -10.9%

1/23 Zymeworks prices $279M equity offering [Seeking Alpha] -7.7%

2/24 Zymeworks to Present at Raymond James 41st Annual Institutional Investors Conference -7.1%

1/27 Form 424B8 Zymeworks Inc. -7.0%

3/3 Zymeworks Inc (NYSE: ZYME) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -6.7%

6/18 Zymeworks Files Preliminary Prospectus Supplements for Offering of Common Shares and Pre-Funded Warrants -6.7%

11/21 Zymeworks Inc (NYSE: ZYME) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. -5.9%

1/10 Zymeworks Inc (NYSE: ZYME) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $61.00 price target on the stock. -5.9%

5/29 Form SC 13G/A Zymeworks Inc. Filed by: CTI Partners, L.P. -5.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day